The Corbevax COVID-19 vaccine was developed by researchers in Texas with no patent, and could be the end of global vaccine inequity.
Accurate at-home COVID-19 test made from coffee capsules
Using materials found around the house, researchers stuck at home created an accurate test to detect COVID-19.
Researchers develop Raman barcodes to keep track of SARS-CoV-2 variants
A fast and efficient means of record keeping could improve the ability to trace structural differences in viral variants.
Omicron reduces vaccine efficacy, but boosters improve protection
Preliminary data indicates that booster shots improve antibody levels 25-fold compared to just two doses.
An inhaled COVID-19 vaccine makes it to human trials
The aerosol platform promises broader protection against SARS-CoV-2, and is currently being trialed as a booster.
Antibodies active against SARS-CoV-2 found in 20-year-old library
Three potent antibodies against SARS-CoV-2 identified in healthy individuals decades ago raises interesting questions about their origins and evolution.
New Pfizer and Merck antivirals look hopeful
With SARS-CoV-2 continuing to circulate, new oral antivirals promise to be game changers in helping to end the pandemic.
Study reveals what makes the Delta variant so infectious
A part of the SARS-CoV-2 spike protein could prove to be its Achilles’ heel.
Biomaterial-based COVID-19 vaccine shows adaptive immunity in mice
A biomaterials platform offers a stable center within the body for antibody development against SARS-CoV-2.
Third shot of COVID-19 vaccine not justified, says research
An expert review finds that booster shots for the general population are not yet necessary since vaccine efficacy against severe COVID-19 remains high.